Baird Financial Group Inc. lowered its stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 3.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,556 shares of the company’s stock after selling 473 shares during the period. Baird Financial Group Inc.’s holdings in Perrigo were worth $352,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Picton Mahoney Asset Management bought a new stake in shares of Perrigo in the first quarter worth about $42,000. Parallel Advisors LLC lifted its holdings in shares of Perrigo by 176.9% during the 1st quarter. Parallel Advisors LLC now owns 1,714 shares of the company’s stock valued at $48,000 after purchasing an additional 1,095 shares in the last quarter. First Horizon Advisors Inc. lifted its holdings in shares of Perrigo by 138.3% during the 1st quarter. First Horizon Advisors Inc. now owns 1,754 shares of the company’s stock valued at $49,000 after purchasing an additional 1,018 shares in the last quarter. Fifth Third Bancorp lifted its holdings in shares of Perrigo by 62.0% during the 1st quarter. Fifth Third Bancorp now owns 2,218 shares of the company’s stock valued at $62,000 after purchasing an additional 849 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of Perrigo by 110.4% during the 1st quarter. Blue Trust Inc. now owns 2,619 shares of the company’s stock valued at $73,000 after purchasing an additional 1,374 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.
Insider Buying and Selling
In related news, Director Geoffrey M. Parker purchased 4,375 shares of the stock in a transaction on Monday, August 18th. The shares were purchased at an average price of $22.97 per share, with a total value of $100,493.75. Following the transaction, the director directly owned 33,287 shares of the company’s stock, valued at $764,602.39. This trade represents a 15.13% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Willis purchased 1,488 shares of the stock in a transaction on Friday, August 22nd. The shares were bought at an average cost of $24.10 per share, for a total transaction of $35,860.80. Following the transaction, the executive vice president directly owned 41,939 shares in the company, valued at approximately $1,010,729.90. The trade was a 3.68% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 10,118 shares of company stock worth $232,699 over the last 90 days. Company insiders own 0.70% of the company’s stock.
Perrigo Stock Up 1.8%
Perrigo (NYSE:PRGO – Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.57 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.02). The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.08 billion. Perrigo had a negative net margin of 1.86% and a positive return on equity of 9.09%. The business’s revenue for the quarter was down .9% on a year-over-year basis. During the same period last year, the company posted $0.53 earnings per share. On average, analysts predict that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.
Perrigo Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 29th will be given a dividend of $0.29 per share. The ex-dividend date of this dividend is Friday, August 29th. This represents a $1.16 annualized dividend and a dividend yield of 5.2%. Perrigo’s payout ratio is -200.00%.
Analyst Ratings Changes
PRGO has been the topic of several recent analyst reports. JPMorgan Chase & Co. cut their price objective on Perrigo from $38.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, August 7th. Wall Street Zen upgraded Perrigo from a “hold” rating to a “buy” rating in a report on Friday, September 5th. Finally, Canaccord Genuity Group cut their price objective on Perrigo from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Thursday, August 7th. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $33.00.
View Our Latest Research Report on Perrigo
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Further Reading
- Five stocks we like better than Perrigo
- Health Care Stocks Explained: Why You Might Want to Invest
- High-Flyers Near Resistance: 3 Stocks to Watch for a Dip
- What is the FTSE 100 index?
- Seagate Technology Leads S&P 500: What’s Behind Its 120% Gain?
- Market Cap Calculator: How to Calculate Market Cap
- Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.